# RxSight, Inc.: Form 8-K, filed Jul 5, 2023

- Company: [RxSight, Inc.](/companies/rxst.md) (CIK 1111485)
- Form: 8-K
- Filed: 2023-07-05
- Accepted by EDGAR: Jul 5, 2023, 06:04 ET
- Period: 2023-06-30
- Accession: 0000950170-23-031482
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/rxst-20230630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 3.03: Change to security holders’ rights
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/rxst-20230630.htm

Filed Jul 5, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-031482. Last ingested by Listed: Nov 3, 2026, 20:44 ET. No prices; not investment advice.